Fischer Medical Ventures: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Fischer Medical Ventures Limited received a certificate for the quarter ended March 31, 2026, under SEBI (Depositories and Participants) Regulations. The RTA confirmed dematerialisation processing and cancellation of old certificates.
This is a standard regulatory compliance filing and does not involve any significant corporate actions or financial events that would materially impact the company.
The announcement is a routine compliance filing and does not contain any information that would positively or negatively impact the company's outlook.
Fischer Medical Ventures Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The certificate was issued by their Registrar and Share Transfer Agent, M/s. Adroit Corporate Services Pvt. Ltd.
Adroit Corporate Services Pvt. Ltd. confirmed that securities received from depository participants for dematerialisation during the quarter were processed and listed on the stock exchanges. They also confirmed that the security certificates received for dematerialisation were mutilated and cancelled after verification, and the depositories' names were substituted in the register of members within 15 days.
The company has requested that this information be taken on record.
What to do with a filing like this
Fischer Medical Ventures Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fischer Medical Ventures Limited. Read the original for the full detail.